Thomas C E, Ohlweiler D F, Kalyanaraman B
Marion Merrell Dow Research Institute, Cincinnati, Ohio 45215.
J Biol Chem. 1994 Nov 11;269(45):28055-61.
Oxidation of low density lipoproteins (LDL) may be a critical atherogenic event owing to the diverse array of biologic effects attributed to modified LDL. Recently, we and others have demonstrated that the lipophilic nitrone spin trap alpha-phenyl-N-tert-butyl nitrone (PBN) can inhibit Cu(2+)-dependent LDL oxidation while the related, more hydrophilic analog alpha-(4-pyridyl-1-oxide)-N-tert-butyl nitrone is ineffective. Because the inhibitory activity of PBN is relatively weak as compared to hydrophobic phenolic antioxidants, we have synthesized a number of cyclic analogues of PBN that encompass a wide range of hydrophobicity and examined their ability to inhibit LDL oxidation in vitro. Formation of a six-membered ring by a bond formed from one methyl of the tert-butyl group to the aromatic ring yielded MDL 101,002, which was 3- and 24-fold more active than PBN against Cu2+ and 2,2'-azobis-2-amidinopropane hydrochloride-dependent oxidation, respectively. The effect of aromatic substituents was examined and, in general, activity positively correlated with hydrophobicity, particularly with Cu2+. Electron spin resonance (ESR) spectroscopy demonstrated that the PBN adduct in oxidized LDL is composed of a mobile component (exposed to the LDL aqueous phase) and an immobilized component, localized in the lipid-protein interface or in the bulk lipid. The most active cyclic nitrones exhibited only highly immobilized adducts, suggesting they are buried within the particle. Studies with MDL 105,185 (which is a chloro-substituted nitrone containing a seven-membered ring rather than six-membered as for MDL 101,002) demonstrated radical trapping in both the lipid and apoprotein fractions. Compounds in which a spirocyclohexyl ring was substituted for the gem-dimethyl methylene (MDL 102,832 and 101,694) formed hydrophobic Cu2+ complexes that were observed in the lipid fraction by ESR. This result was confirmed by fractionation of LDL oxidation reaction mixtures and spectrophotometric quantitation of associated Cu2+. The ability to bind Cu2+ was dependent upon the presence of the spirocyclohexyl ring. These data demonstrate that cyclic nitrones can inhibit LDL oxidation at exceedingly low concentrations by multiple mechanisms: 1) trapping of lipid-derived radicals, 2) trapping of apoprotein B-derived radicals, and 3) binding of Cu2+ ions. It is suggested that this new class of highly potent spin traps may be used as effective radical traps in free radical biology and medicine.
由于修饰的低密度脂蛋白(LDL)具有多种生物学效应,LDL的氧化可能是一个关键的致动脉粥样硬化事件。最近,我们和其他人已经证明,亲脂性硝酮自旋捕获剂α-苯基-N-叔丁基硝酮(PBN)可以抑制Cu(2+)依赖性LDL氧化,而相关的、更具亲水性的类似物α-(4-吡啶基-1-氧化物)-N-叔丁基硝酮则无效。由于与疏水性酚类抗氧化剂相比,PBN的抑制活性相对较弱,我们合成了许多PBN的环状类似物,它们具有广泛的疏水性,并研究了它们在体外抑制LDL氧化的能力。通过由叔丁基的一个甲基与芳环形成的键形成六元环,得到MDL 101,002,其对Cu2+和2,2'-偶氮双(2-脒基丙烷)盐酸盐依赖性氧化的活性分别比PBN高3倍和24倍。研究了芳环取代基的影响,一般来说,活性与疏水性呈正相关,特别是与Cu2+相关。电子自旋共振(ESR)光谱表明,氧化LDL中的PBN加合物由一个可移动成分(暴露于LDL水相)和一个固定成分组成,该固定成分位于脂质-蛋白质界面或脂质体中。活性最高的环状硝酮仅表现出高度固定的加合物,表明它们被埋在颗粒内。对MDL 105,185(它是一种含七元环而非MDL 101,002的六元环的氯取代硝酮)的研究表明,脂质和载脂蛋白部分均存在自由基捕获。用螺环己基环取代偕二甲基亚甲基的化合物(MDL 102,832和101,694)形成了疏水性Cu2+络合物,通过ESR在脂质部分中观察到。通过对LDL氧化反应混合物进行分级分离并对相关Cu2+进行分光光度法定量,证实了这一结果。结合Cu2+的能力取决于螺环己基环的存在。这些数据表明,环状硝酮可以通过多种机制在极低浓度下抑制LDL氧化:1)捕获脂质衍生的自由基,2)捕获载脂蛋白B衍生的自由基,3)结合Cu2+离子。有人提出,这类新型的高效自旋捕获剂可作为自由基生物学和医学中有效的自由基捕获剂。